Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 92

Sort by

Sort Order Select

Journal Articles

CCR1-Targeting CAR T Cells for Acute Myeloid Leukemia

Sophia Chen, Alexander P. Boardman, Scott E. James, Marcel R.M. van den Brink

Blood (2023) 142 (Supplement 1): 4808.

https://doi.org/10.1182/blood-2023-184464

Published: 2023

Journal Articles

Recirculating Regulatory T Cells Mediate Thymic Regeneration in a ZFP36L1 and Amphiregulin Dependent Manner

Andri Leo L Lemarquis, Anastasia Kousa, Kimon V Argyropoulos, Lorenz Jahn, Brianna Gipson, Lucia Serrano-Marin, Hana Andrlova, Jennifer Tsai, Jarrod A Dudakov, Susan DeWolf, Marcel R.M. van den Brink

Blood (2023) 142 (Supplement 1): 457.

https://doi.org/10.1182/blood-2023-183036

Published: 2023

Journal Articles

Bacterial and Bacteriophage Consortia Are Associated with Protective Intestinal Immuno-Modulatory Metabolites in Allogeneic Stem Cell Transplantation Patients

Blood (2023) 142 (Supplement 1): 477.

https://doi.org/10.1182/blood-2023-172457

Published: 2023

Journal Articles

Preliminary Safety Results of the Open-Label Phase of a 2-Part Phase 1b Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of an Investigational Microbiome Therapeutic, SER-155, in Adults Undergoing Hematopoietic Cell Transplantation

Doris M. Ponce, Satyajit Kosuri, Nandita Khera, Zachariah Defilipp, David I Lichter, Jonathan U Peled, Marcel R.M. van den Brink, Kelly Brady, Matthew D Puhl, Gabrielle Glick, Brooke Hasson, Barbara H McGovern, Lisa von Moltke, Bina Tejura

Blood (2023) 142 (Supplement 1): 6994.

https://doi.org/10.1182/blood-2023-180119

Published: 2023

Journal Articles

Impact of Investigational Microbiome Therapeutic SER-155 on Pathogen Domination: Initial Results from a Phase 1b Study in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT)

Jonathan U. Peled, Marcel R.M. van den Brink, Doris M. Ponce, Satyajit Kosuri, Nandita Khera, Zachariah DeFilipp, Bina Tejura, David I Lichter, Mary-Jane Lombardo, Meghan Chafee, Jennifer R Wortman, Timothy Straub, Emily Walsh, Augustus Ge, David Lyttle, Brooke Hasson, Christopher Ford, Lisa von Moltke, Matthew Henn

Blood (2023) 142 (Supplement 1): 2198.

https://doi.org/10.1182/blood-2023-188885

Published: 2023

Journal Articles

Cryopreservation Changes the Immune Effector Cell Composition of Peripheral Blood Stem Cell Grafts: An Analysis from the DKMS and NMDP Graft Composition Study

Blood (2023) 142 (Supplement 1): 1036.

https://doi.org/10.1182/blood-2023-179140

Published: 2023

Journal Articles

Enterococcus Induces MHC-II Expression in the Colonic Epithelium to Aggravate Graft-Versus-Host Disease

Chi L Nguyen, Marina Burgos da Silva, Romina Ghale, Kristen Victor, Anqi Dai, Melissa Docampo, Kate A. Markey, Jonathan U. Peled, Marcel R.M. van den Brink

Blood (2023) 142 (Supplement 1): 344.

https://doi.org/10.1182/blood-2023-186759

Published: 2023

Journal Articles

Low CD117 Expression Identifies Hematopoietic Stem Cell Subsets with Enhanced Lymphoid Potential in Mice and Humans

Harold K Elias, Sneha Mitra, Brianna Gipson, Marina Burgos da Silva, Nicole Lee, Mohamed A.E. Ali, Simon Grassman, Anastasia Kousa, Susan DeWolf, Christopher Y. Park, Joseph Sun, Christina Leslie, Avinash Bhandoola, Marcel R.M. van den Brink

Blood (2023) 142 (Supplement 1): 3417.

https://doi.org/10.1182/blood-2023-190000

Published: 2023

Journal Articles

An Inflammatory Biomarker Signature Reproducibly Predicts CAR-T Treatment Failure in Patients with Aggressive Lymphoma across the Zuma Trials Cohorts

Sandeep Raj, Jin Xie, Teng Fei, Qinghua Song, Jenny J. Kim, Christina To, Marcel R.M. van den Brink, Miguel-Angel Perales, Mike Mattie, Roni Shouval

Blood (2023) 142 (Supplement 1): 224.

https://doi.org/10.1182/blood-2023-173798

Published: 2023

Journal Articles

MAIT Cell Frequencies within PBSC Grafts Are Associated with Donor CMV Serostatus and Age: An Initial Analysis from the DKMS and NMDP Graft Composition Study

Blood (2023) 142 (Supplement 1): 1033.

https://doi.org/10.1182/blood-2023-185153

Published: 2023

Journal Articles

A Whole Foods Plant-Based Weight Loss Intervention Improves Quality of Life, Metabolic, Microbiome and Immune Profile in MGUS/SMM As Well As Progression Trajectory in a Subset - the Nutrivention Trial

Blood (2023) 142 (Supplement 1): 4771.

https://doi.org/10.1182/blood-2023-182878

Published: 2023

Journal Articles

Use of a Tissue-Targeting Recombinant Human Interleukin-22 Fusion Molecule (F-652) for the Treatment of Advanced Refractory Lower GI Acute Gvhd

Toshihisa Satta, Esperanza B. Papadopoulos, Boglarka Gyurkocza, Pamela Susman, Amandeep Singh, Marco Calafiore, Sergio A. Giralt, Miguel-Angel Perales, Jianmin Chen, Simon Li, Jonathan U. Peled, Marcel R.M. van den Brink, Alan M. Hanash, Doris M. Ponce

Blood (2023) 142 (Supplement 1): 7019.

https://doi.org/10.1182/blood-2023-181269

Published: 2023

Journal Articles

Clonal Hematopoiesis Is Common in Unrelated Stem Cell Donors but Has No Impact on Patient Outcome after Hematopoietic Stem Cell Transplantation

Blood (2023) 142 (Supplement 1): 942.

https://doi.org/10.1182/blood-2023-179112

Published: 2023

Journal Articles

A Randomized Placebo Controlled Study of a Plant-Based Dietary Versus Supplement Versus Placebo Intervention in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma (SMM) - the Nutrition Prevention (NUTRIVENTION-3) Study

Blood (2022) 140 (Supplement 1): 5052–5055.

https://doi.org/10.1182/blood-2022-159794

Published: 2022

Journal Articles

A Pilot Plant Based Dietary Intervention in MGUS and SMM Patients with Elevated BMI Is Feasible and Associated with Improvements in Metabolic and Microbiome Biomarkers of Progression

Blood (2022) 140 (Supplement 1): 5066–5069.

https://doi.org/10.1182/blood-2022-163281

Published: 2022

Journal Articles

Tracking Immune Reconstitution in the Bone Marrow Following Allogeneic Hematopoietic Transplantation in Humans Reveals Early Dominance of Innate Lymphoid Populations

Blood (2022) 140 (Supplement 1): 4759–4761.

https://doi.org/10.1182/blood-2022-159303

Published: 2022

Journal Articles

RIG-I Activation Is Critical for Responsiveness to Checkpoint Blockade

Simon Heidegger, MD, Alexander Wintges, Florian Stritzke, Katja Steiger, Paul-Albert Koenig, Thomas Engleitner, Julius Clemens Fischer, Vladimir Makarov, Christof Winter, Roland Rad, Marcel R.M. van den Brink, MD PhD, Jürgen Ruland, Florian Bassermann, MD PhD, Timothy Chan, Tobias Haas, MD, Hendrik Poeck, MD

Blood (2019) 134 (Supplement_1): 624.

https://doi.org/10.1182/blood-2019-128724

Published: 2019

Journal Articles

Antibiotic Exposures and Dietary Intakes Are Associated with Changes in Microbiota Compositions in Allogeneic Hematopoietic Stem Cell Transplant Patients

Chi L. Nguyen, BA, Antonio L.C. Gomes, PhD, Jonathan U. Peled, MD PhD, John B. Slingerland, BSc, Ann E. Slingerland, BSc, Marissa L. Buchan, MS, Peter A. Adintori, MS, RD, CDN, Kate A Markey, PhDMBBS,FRACP, Annelie Clurman, BA, Molly A. Maloy, MS, Sergio A. Giralt, MD, Miguel-Angel Perales, MD, Ying Taur, MD MPH, Xavier B. Joao, PhD, Eric G. Pamer, MD, Marcel R.M. van den Brink, MD PhD

Blood (2019) 134 (Supplement_1): 597.

https://doi.org/10.1182/blood-2019-130578

Published: 2019

Journal Articles

Sparing of the Lower Gastrointestinal Tract Microbiota Is Associated with Reduced Acute Graft-Versus-Host Disease

Doris M Ponce, MD, Marina D Burgos da Silva, PhD, Antonio L.C. Gomes, PhD, Gillian Moore, BA, John B. Slingerland, BSc, Eric G. Pamer, MD, Ying Taur, MD MPH, Jonathan U. Peled, MD PhD, Marcel R.M. van den Brink, MD PhD

Blood (2019) 134 (Supplement_1): 4538.

https://doi.org/10.1182/blood-2019-131067

Published: 2019

Journal Articles

The Blood Microbiome Predicts Acute Graft-Versus-Host Disease after Stem Cell Transplantation

Lily Blair, PhD, Jonathan U. Peled, MD, Paul A Giardina, John B. Slingerland, BSc, Ann E. Slingerland, BSc, Desiree Hollemon, MPH, MSN, Carine Ho, Sivan Bercovici, Asim Ahmed, David K Hong, MD, Sergio A. Giralt, MD, Ying Taur, MD MPH, Marcel R.M. van den Brink, MD PhD, Kate A Markey, PhDMBBS,FRACP

Blood (2019) 134 (Supplement_1): 4513.

https://doi.org/10.1182/blood-2019-129272

Published: 2019

NARROW

CCR1-Targeting CAR T Cells for Acute Myeloid Leukemia

Recirculating Regulatory T Cells Mediate Thymic Regeneration in a ZFP36L1 and Amphiregulin Dependent Manner

Bacterial and Bacteriophage Consortia Are Associated with Protective Intestinal Immuno-Modulatory Metabolites in Allogeneic Stem Cell Transplantation Patients

Preliminary Safety Results of the Open-Label Phase of a 2-Part Phase 1b Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of an Investigational Microbiome Therapeutic, SER-155, in Adults Undergoing Hematopoietic Cell Transplantation

Impact of Investigational Microbiome Therapeutic SER-155 on Pathogen Domination: Initial Results from a Phase 1b Study in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT)

Cryopreservation Changes the Immune Effector Cell Composition of Peripheral Blood Stem Cell Grafts: An Analysis from the DKMS and NMDP Graft Composition Study

Enterococcus Induces MHC-II Expression in the Colonic Epithelium to Aggravate Graft-Versus-Host Disease

Low CD117 Expression Identifies Hematopoietic Stem Cell Subsets with Enhanced Lymphoid Potential in Mice and Humans

An Inflammatory Biomarker Signature Reproducibly Predicts CAR-T Treatment Failure in Patients with Aggressive Lymphoma across the Zuma Trials Cohorts

MAIT Cell Frequencies within PBSC Grafts Are Associated with Donor CMV Serostatus and Age: An Initial Analysis from the DKMS and NMDP Graft Composition Study

A Whole Foods Plant-Based Weight Loss Intervention Improves Quality of Life, Metabolic, Microbiome and Immune Profile in MGUS/SMM As Well As Progression Trajectory in a Subset - the Nutrivention Trial

Use of a Tissue-Targeting Recombinant Human Interleukin-22 Fusion Molecule (F-652) for the Treatment of Advanced Refractory Lower GI Acute Gvhd

Clonal Hematopoiesis Is Common in Unrelated Stem Cell Donors but Has No Impact on Patient Outcome after Hematopoietic Stem Cell Transplantation

A Randomized Placebo Controlled Study of a Plant-Based Dietary Versus Supplement Versus Placebo Intervention in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma (SMM) - the Nutrition Prevention (NUTRIVENTION-3) Study

A Pilot Plant Based Dietary Intervention in MGUS and SMM Patients with Elevated BMI Is Feasible and Associated with Improvements in Metabolic and Microbiome Biomarkers of Progression

Tracking Immune Reconstitution in the Bone Marrow Following Allogeneic Hematopoietic Transplantation in Humans Reveals Early Dominance of Innate Lymphoid Populations

RIG-I Activation Is Critical for Responsiveness to Checkpoint Blockade

Antibiotic Exposures and Dietary Intakes Are Associated with Changes in Microbiota Compositions in Allogeneic Hematopoietic Stem Cell Transplant Patients

Sparing of the Lower Gastrointestinal Tract Microbiota Is Associated with Reduced Acute Graft-Versus-Host Disease

The Blood Microbiome Predicts Acute Graft-Versus-Host Disease after Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only